×
Jupiter Neurosciences Net Profit Margin 1971-1970 | JUNS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Jupiter Neurosciences net profit margin from 1971 to 1970. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Jupiter Neurosciences Net Profit Margin 1971-1970 | JUNS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Jupiter Neurosciences net profit margin from 1971 to 1970. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Zoetis (ZTS)
$73.8B
Chugai Pharmaceutical (CHGCY)
$70.2B
Takeda Pharmaceutical (TAK)
$41.4B
Merck (MKKGY)
$18.5B
Sandoz Group AG (SDZNY)
$18.2B
Astellas Pharma (ALPMY)
$17.5B
United Therapeutics (UTHR)
$16.1B
Neurocrine Biosciences (NBIX)
$13.7B
Summit Therapeutics (SMMT)
$13.6B
Shionogi (SGIOY)
$11.7B
Madrigal Pharmaceuticals (MDGL)
$6.4B
Orion OYJ (ORINY)
$6.2B
Ionis Pharmaceuticals (IONS)
$5.6B
Corcept Therapeutics (CORT)
$5.4B
Crinetics Pharmaceuticals (CRNX)
$4.9B
PTC Therapeutics (PTCT)
$3.5B
Catalyst Pharmaceuticals (CPRX)
$2.6B
Dyne Therapeutics (DYN)
$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.4B
NewAmsterdam Pharma (NAMS)
$2.4B
Centessa Pharmaceuticals (CNTA)
$2.3B
Soleno Therapeutics (SLNO)
$1.9B
Recursion Pharmaceuticals (RXRX)
$1.7B
Xencor (XNCR)
$1.7B
Indivior (INDV)
$1.6B
Evotec AG (EVO)
$1.6B
BioCryst Pharmaceuticals (BCRX)
$1.5B
Guardian Pharmacy Services (GRDN)
$1.4B
Ocular Therapeutix (OCUL)
$1.3B
Aurinia Pharmaceuticals Inc (AUPH)
$1.3B